Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 24.6% in September

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) was the target of a large increase in short interest in September. As of September 15th, there was short interest totalling 1,420,000 shares, an increase of 24.6% from the August 31st total of 1,140,000 shares. Currently, 4.1% of the company’s stock are short sold. Based on […]

Related Keywords

Montreal ,Quebec ,Canada ,Black Diamond ,Alberta ,Ali Behbahani ,Stifel Nicolaus ,Piper Sandler ,Herbst Group ,Charles Schwab Investment Management Inc ,Capital Management ,Nasdaq ,Diamond Therapeutics Company Profile ,Securities Exchange Commission ,Cubist Systematic Strategies ,Diamond Therapeutics Inc ,Black Diamond Therapeutics ,Get Free Report ,Director Ali Behbahani ,Exchange Commission ,Schwab Investment Management ,Montreal Can ,Systematic Strategies ,Diamond Therapeutics Stock Down ,Diamond Therapeutics ,Black Diamond Therapeutics Daily ,Nasdaq Bdtx ,Bdtx ,Medical ,Stocks ,Options ,Put ,Call ,